Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'

Immunological Reviews

Volumn 211, Issue , 2006, Pages 310-319

  Zinkernagel, Rolf M ^a   Hengartner, Hans ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY TITER; B LYMPHOCYTE; CELL STIMULATION; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOPATHOLOGY; INFECTION; INFECTION RESISTANCE; MEMORY CELL; MEMORY T LYMPHOCYTE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTECTION; REINFECTION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES; HUMANS; IMMUNITY, NATURAL; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES;

EID: 33745098337     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2006.00402.x     Document Type: Review

References (58)

1. Fenner F McAusland B Mims C Sambrook J. The Biology of Animal Viruses. London: Academic Press, 1974.
2. Mims CA. Pathogenesis of Infectious Disease. London: Academic Press, 1987.
3. Fenner F. Mousepox (infectious ectromelia of mice): a review. J Immunol 1949 63: 341 373.
4. Sabin AB Albrecht P Takeda AK Ribeiro EM Veronesi R. High effectiveness of aerosolized chick embryo fibroblast measles vaccine in seven-month-old and older infants. J Infect Dis 1985 152: 1231 1237.
5. Janeway C Travers P Walport M Shlomchik M. Immunobiology: the Immune System in Health and Disease. New York: Garland Publishing, 2001.
6. Zinkernagel RM Bachmann MF Kuendig TM Oehen S Pircher HP Hengartner H. On immunological memory. Annu Rev Immunol 1996 14: 333 367.
7. Zinkernagel RM. On natural and artificial vaccinations. Annu Rev Immunol 2003 21: 515 546.
8. Jamieson BD Ahmed R. T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J Exp Med 1989 169: 1993 2005.
9. Mackay CR. Immunological memory. Adv Immunol 1993 53: 217 265.
10. Zinkernagel RM. Antiviral T-cell memory? Curr Top Microbiol Immunol 1990 159: 65 77.
11. Zinkernagel RM. What is missing in immunology to understand immunity? Nat Immun 2000 1: 181 185.
12. Goldsby RA Kindt TJ Osborne BA. Kuby Immunology. New York: W.H. Freeman and Company, 2000.
13. Zinkernagel RM. Immunology taught by viruses. Science 1996 271: 173 178.
14. Zinkernagel RM. Maternal antibodies, childhood infections and autoimmune diseases. N Engl J Med 2001 345: 1331 1335.
15. Baldridge JR Buchmeier MJ. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J Virol 1992 66: 4252 4257.
16. Siegrist CA, et al. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol 1998 28: 4138 4148.
17. Ehrlich P. Ueber Immunitaet durch Vererbung und Saeugung. Z Hyg Infektkr 1882 12: 183.
18. Brambell RWR. The Transmission of Immunity from Mother to Young. Amsterdam: North Holland Publinshing Corp., 1970.
19. Bloom BR McKinney JD. The death and resurrection of tuberculosis [news]. Nat Med 1999 5: 872 874.
20. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993 11: 129 163.
21. Zinkernagel RM. On immunological memory. Philos Trans R Soc Lond B Biol Sci 2000 355: 369 371.
22. Zinkernagel RM. On differences between immunity and immunological memory. Curr Opin Immunol 2002 14: 523 536.
23. Steinhoff U Mueller U Schertler A Hengartner H Aguet M Zinkernagel RM. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J Virol 1995 69: 2153 2158.
24. Ochsenbein AF Pinschewer DD Sierro S Horvath E Hengartner H Zinkernagel RM. Protective long-term antibody memory by antigen-driven and T help- dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc Natl Acad Sci USA 2000 97: 13263 13268.
25. Manz RA Thiel A Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997 388: 133 134.
26. Slifka MK Matloubian M Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 1995 69: 1895 1902.
27. Slifka MK Antia R Whitmire JK Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998 8: 363 372.
28. Slifka MK Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998 10: 252 258.
29. Sallusto F Lenig D Forster R Lipp M Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401: 708 712.
30. Manz RA Hauser AE Hiepe F Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005 23: 367 386.
31. Rajewsky K Schirrmacher V Nase S Jerne NK. The requirement of more than one antigenic determinant for immunogenicity. J Exp Med 1969 129: 1131 1143.
32. Mitchison NA. The carrier effect in the secondary response to hapten-protein conjugates. V. Use of antilymphocyte serum to deplete animals of helper cells. Eur J Immunol 1971 1: 68 75.
33. Katz DH Benacerraf B. The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol 1972 15: 1 94.
34. Gupta SC Hengartner H Zinkernagel RM. Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: analysis in a viral model. Proc Natl Acad Sci USA 1986 83: 2604 2608.
35. Bos NA Meeuwsen CG. B cell repertoire in adult antigen-free and conventional neonatal BALB/c mice. I. Preferential utilisation of the CH-proximal VH gene family PC7183. Eur J Immunol 1989 19: 1811 1815.
36. Liang S Mozdzanowska K Palladino G Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 1994 152: 1653 1661.
37. Hotchin J. The biology of lymphocytic choriomeningitis infection: virus induced immune disease. Cold Spring Harb Symp Quant Biol 1962 27: 479 499.
38. Lehmann-Grube F. Lymphocytic choriomeningitis virus. Virol Monogr 1971 10: 1 173.
39. Buchmeier MJ Welsh RM Dutko FJ Oldstone MBA. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 1980 30: 275 331.
40. Ehl S Klenerman P Aichele P Hengartner H Zinkernagel RM. A functional and kinetic comparison of antiviral effector and memory cytotoxicT lymphocyte population in vivo and in vitro. Eur J Immunol 1997 27: 3404 3413.
41. Moskophidis D Lechner F Pircher HP Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993 362: 758 761.
42. Ahmed R Salmi A Butler LD Chiller JM Oldstone MB. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 1984 160: 521 540.
43. Kündig TM, et al. On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci USA 1996 93: 9716 9723.
44. Traub E. A filterable virus recovered from white mice. Science 1935 81: 298 299.
45. Gray D Skarvall H. B cell memory is short-lived in the absence of antigen. Nature 1988 336: 70 73.
46. Gray D Matzinger P. T cell memory is short-lived in the absence of antigen. J Exp Med 1991 174: 969 974.
47. Billeter MA, et al. Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci 1994 724: 367 377.
48. Katayama Y Hotta H Nishimura A Tatsuno Y Homma M. Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J Gen Virol 1995 76: 3201 3204.
49. Bernasconi NL Traggiai E Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002 298: 2199 2202.
50. Oldstone MB. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 1997 234: 179 185.
51. Klenerman P Wu Y Phillips R. HIV: current opinion in escapology. Curr Opin Microbiol 2002 5: 408 413.
52. Bowen DG Walker CM. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 2005 201: 1709 1714.
53. Swanson J Belland RJ Hill SA. Neisserial surface variation: how and why? Curr Opin Genet Dev 1992 2: 805 811.
54. Borst P Fairlamb AH. Surface receptors and transporters of Trypanosoma brucei. Annu Rev Microbiol 1998 52: 745 778.
55. Miller LH Good MF. The main obstacle to a malaria vaccine: the malaria parasite. Vaccine 1988 6: 104 106.
56. Pircher HP Rohrer UH Moskophidis D Zinkernagel RM Hengartner H. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature 1991 351: 482 485.
57. Ochsenbein AF, et al. A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci USA 1999 96: 9293 9298.
58. Ochsenbein AF Pinschewer DD Odermatt B Carroll MC Hengartner H Zinkernagel RM. Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med 1999 190: 1165 1174.